Patents by Inventor Martin John Packer

Martin John Packer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMICAL COMPOUNDS
    Publication number: 20220227768
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Application
    Filed: April 7, 2022
    Publication date: July 21, 2022
    Inventors: Jeffrey Wallace Johannes, Sudhir Mahadeo Hande, Sebastien Louis Degorce, Martin John Packer
  • Chemical compounds
    Patent number: 11325906
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: May 10, 2022
    Assignee: ASTRAZENECA AB
    Inventors: Jeffrey Wallace Johannes, Sudhir Mahadeo Hande, Sebastien Louis Degorce, Martin John Packer
  • Phenoxyquinazoline compounds and their use in treating cancer
    Patent number: 11053223
    Abstract: The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation, pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: July 6, 2021
    Assignee: AstraZeneca AB
    Inventors: Tudor Grecu, Jason Grant Kettle, Martin John Packer, Stuart Eric Pearson, James Michael Smith
  • CHEMICAL COMPOUNDS
    Publication number: 20210040084
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Application
    Filed: July 17, 2020
    Publication date: February 11, 2021
    Inventors: Jeffrey Wallace JOHANNES, Sudhir Mahadeo HANDE, Sebastien Louis DEGORCE, Martin John PACKER
  • PHENOXYQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER
    Publication number: 20200223828
    Abstract: The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their preparation, pharmaceutical compositions containing them and their use in treating KIT mediated diseases.
    Type: Application
    Filed: April 26, 2018
    Publication date: July 16, 2020
    Inventors: Tudor GRECU, Jason Grant KETTLE, Martin John PACKER, Stuart Eric PEARSON, James Michael SMITH
  • Pyrazole derivatives as 11-beta-HSD1 inhibitors
    Patent number: 8344016
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: January 1, 2013
    Assignee: AstraZeneca AB
    Inventors: Martin John Packer, James Stewart Scott, Andrew Stocker, Paul Robert Owen Whittamore
  • Pyrazole Derivatives as 11-Beta-HSD1 Inhibitors
    Publication number: 20110224273
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Application
    Filed: September 9, 2010
    Publication date: September 15, 2011
    Applicant: AstraZeneca AB
    Inventors: Martin John Packer, James Stewart Scott, Andrew Stocker, Paul Robert Owen Whittamore
  • Crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]Benzoic acid 471
    Patent number: 7951833
    Abstract: New crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Grant
    Filed: February 3, 2009
    Date of Patent: May 31, 2011
    Assignee: AstraZeneca AB
    Inventors: Gary Peter Tomkinson, Martin John Packer, James Stewart Scott, Paul Robert Owen Whittamore, Andrew Stocker
  • Chemical compounds
    Patent number: 7816391
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Grant
    Filed: October 28, 2008
    Date of Patent: October 19, 2010
    Assignee: AstraZeneca AB
    Inventors: Martin John Packer, James Stewart Scott, Andrew Stocker, Paul Robert Owen Whittamore
  • PYRAZOLE DERIVATIVES AS 11-BETA-HSD1 INHIBITORS
    Publication number: 20090221663
    Abstract: A compound of Formula (I): and pharmaceutically-acceptable salts thereof wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Application
    Filed: October 28, 2008
    Publication date: September 3, 2009
    Applicant: AstraZeneca AB
    Inventors: Martin John Packer, James Stewart Scott, Andrew Stocker, Paul Robert Owen Whittamore